U.S. Regulators Cleared a New Eli Lilly Monoclonal Antibody for Patients at High Risk of ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'U.S. regulators cleared a new Eli Lilly monoclonal antibody for patients at high risk of mild to moderate Covid-19 ...'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)